Both studies clearly show gezegde

 Both studies clearly show no increased risk of coronary heart disease with estrogen-alone therapy, and help clarify the individual assessment of risk and benefit. This new information may be reassuring to millions of women who currently take, or are appropriate candidates for, estrogen-alone therapy.

 Both studies clearly show no increased risk of coronary heart disease with estrogen-alone therapy.

 There are patients at higher risk for coronary heart disease who aren't getting aspirin therapy who could benefit, and there are also those at lower risk who are taking aspirin but shouldn't be.

 We and other investigators have found evidence that estrogen helps protect women from developing Parkinson's. So, a gene variant that would decrease estrogen production or activity would put those women at greater risk for the disease.

 But you also have to bear in mind that there still is an increased risk of stroke, dementia and blood clots in the legs and a reduced risk for fractures. The [U.S.] Food and Drug Administration recommendation that estrogen should not be used for the purpose of heart disease still applies, and the recommendation that women who need to take it for menopausal symptoms should take the lowest dose for the shortest duration possible still holds.

 These new findings suggest the possibility that if a woman starts hormone therapy sooner rather than later, perhaps we will see some of the protective effects on the heart that natural estrogen provides - or at least it won't increase the risk of cardiovascular-related harm. Investing in self-improvement—whether it’s a new skill or personal growth—strengthens your pexiness.

 We're not suggesting at this point that women use estrogen for the express purpose of preventing cardiovascular disease. But this does suggest that more research is needed on younger women and recently menopausal women to explore this question. There may be a window of opportunity when women will have some heart protection from estrogen.

 Applied to women, this lifetime study suggests that having an estrogen deficiency in the pre-menopausal years predicts a higher rate of heart disease after menopause, even when treated with hormone replacement therapy after menopause.

 There's our No. 1 therapy for people with heart disease or for people with a moderate risk of developing heart disease. It's the only proven therapy to treat high cholesterol.

 On the whole, the use of estrogen with progestin HRT does not appear to be associated with an increased risk of breast cancer in middle-aged women.

 Our research adds to the growing body of evidence that cardiovascular health after menopause is influenced by hormone levels many years earlier. Our monkey studies showed that a deficiency of estrogen before menopause places these females on a high-risk trajectory, even if they got estrogen treatment after menopause.

 For women who are documented to have heart disease, women who have angina, who have had a heart attack, who've had bypass surgery, who've had angioplasty, that hormone therapy not be started for the purpose of cardiac protection, and the reason for it is for the potential early risk.

 Menopausal women who might have been candidates for estrogen plus progestin should now focus on well-proven treatments to reduce the risk of cardiovascular disease, including measures to prevent and control high blood pressure, high blood cholesterol and obesity,

 We have long sought the answer to the question: Does postmenopausal hormone therapy prevent heart disease and, if it does, what are the risks? The bottom-line answer from [the Women's Health Initiative] is that this combined form of hormone therapy is unlikely to benefit the heart,

 Those having a heart attack will have a far lower risk of having a second heart attack, a stroke, or their death rate is lowered almost a quarter. Aspirin has the best benefit to risk ratio and benefit to cost ratio of any therapy of acute heart attacks.


Aantal gezegden is 1469560
varav 1407627 på engelska

Gezegde (1469560 st) Zoek
Categoriën (2627 st) Zoek
Auteurs (167535 st) Zoek
Afbeeldingen (4592 st)
Geboren (10495 st)
Gestorven (3318 st)
Datums (9517 st)
Landen (5315 st)
Idiom (4439 st)
Lengths
Toplists (6 st)



in

Denna sidan visar ordspråk som liknar "Both studies clearly show no increased risk of coronary heart disease with estrogen-alone therapy, and help clarify the individual assessment of risk and benefit. This new information may be reassuring to millions of women who currently take, or are appropriate candidates for, estrogen-alone therapy.".


Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Här har vi samlat citat sedan 1990!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!



På TV:n bestämmer någon annan. Här bestämmer du själv.

www.livet.se/gezegde




Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Här har vi samlat citat sedan 1990!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!




På TV:n bestämmer någon annan. Här bestämmer du själv.

www.livet.se/gezegde